Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting
JCO Oncology Practice · 2025-05 · 21 (5) · 596-598
DOI: 10.1200/op-24-00921 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Oncology Practice, 2025-05. Verfasst von Daniel J Olivieri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, WA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, University of Washington, Seattle, WA.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
ORCID-Profile: Daniel J Olivieri, Rahul Banerjee
Zitieren
APA
Olivieri, D. J., & Banerjee, R. (2025). Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting. JCO Oncology Practice, 21(5), 596-598. https://doi.org/10.1200/op-24-00921
Vancouver
Olivieri DJ, Banerjee R. Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting. JCO Oncology Practice. 2025;21(5):596-598. doi:10.1200/op-24-00921
BibTeX
@article{Olivieri2025,
author = {Olivieri, Daniel J and Banerjee, Rahul},
title = {Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting},
journal = {JCO Oncology Practice},
year = {2025},
volume = {21},
number = {5},
pages = {596--598},
doi = {10.1200/op-24-00921}
}
EUVIMED